VERTICAL Phase II trial results for NHL released
The Takeda Oncology Company today reported data from a clinical trial evaluating a VELCADE based combination for patients with relapsed/refractory non-Hodgkin’s lymphoma (NHL).

Read more on News-Medical-Net


Unsubscribe
SP Beauty Lift
P.O. Box 2718-SPBL
Riverton, UT 84065
Please note: It may take up to 10 business days for your name to be removed from our list.

If you have trouble seeing the images below, click here.

Please load images in your email client to view this email correctly